Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
10.06
+2.44 (32.02%)
Apr 17, 2025, 4:00 PM EDT - Market closed

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21
Market Capitalization
477---
Enterprise Value
488---
Debt / Equity Ratio
0.250.270.180.09
Debt / EBITDA Ratio
1.621.300.760.44
Debt / FCF Ratio
1.862.20-2.35
Asset Turnover
0.380.420.54-
Inventory Turnover
1.421.622.17-
Quick Ratio
0.730.770.950.86
Current Ratio
1.381.371.411.31
Return on Equity (ROE)
7.15%10.78%16.50%-
Return on Assets (ROA)
3.82%5.51%8.59%-
Return on Capital (ROIC)
4.48%6.61%10.75%-
Return on Capital Employed (ROCE)
8.70%12.90%18.00%16.40%
Payout Ratio
-125.42%45.84%28.36%
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q